Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 114 (5) , 880-884
- https://doi.org/10.1016/s0022-3476(89)80158-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Noncompartmental Determination of the Steady-State Volume of Distribution for Any Mode of AdministrationJournal of Pharmaceutical Sciences, 1982
- Developmental Aspects of Drug Conjugation, with Special Reference to GlucuronidationAnnual Review of Pharmacology and Toxicology, 1978